Apptio is being taken private by investment firm Vista Equity Partners in a $1.94 billion acquisition.
It’s hard to say no to $8 billion. Qualtrics, the enterprise software firm that was on the verge of going public, has pulled its IPO in favor of selling to German software giant SAP for $8 billion in cash.
Qualtrics—which has... Read more »
The gene-editing technology CRISPR-Cas9 is opening up new research avenues all the time, such as giving drug developers a cheaper, faster way to knock out genes in tumor cells.
Studies of CRISPR-Cas9 to treat human disease are about to start,... Read more »
In some ways, the biggest software acquisition of all time could be a yawner.
IBM’s planned $34 billion deal to acquire open-source software maker Red Hat is a hefty price to pay to give its cloud computing business a shot in... Read more »
Facebook (NASDAQ: FB) shares gained nearly 3 percent Tuesday, and ticked up further in after-hours trading following the release of a third quarter earnings report that showed some strengths as well as shortfalls. Investors have been concerned about the social... Read more »
The U.K.’s data privacy regulator fined Facebook $645,000 for violations that allowed political marketing firm Cambridge Analytica and other outside companies to extract 87 million Facebook profiles worldwide without adequate user knowledge or consent.
The purpose of the U.K.’s enforcement actions... Read more »
In the biotech investment and research communities this week, much of the attention was turned to Europe.
Munich, Germany, hosted the annual conference of the European Society for Medical Oncology, where cancer drug developers unveiled the latest clinical data for experimental... Read more »
[Updated 5:41pm ET with analyst note, see below.] When the Trump administration announced its blueprint for lowering prescription drug prices in May, many observers said it was too soft on the biopharma industry and didn’t contain concrete initiatives... Read more »
The current land rush in chip development, spurred as new technologies such as artificial intelligence create new needs, is pitting established semiconductor companies like Intel and Nvidia against tech titans like Facebook that are building their own chips. A wave of... Read more »
[Ben Fidler co-authored this report.] The European Society for Medical Oncology is wrapping up its annual conference today, replete with clinical data from cancer’s front lines. We’ve sorted the headlines into a few big categories: immunotherapy combinations, breast cancer,... Read more »
Security-tech company Cybereason is announcing another boon flowing from close ties with its biggest investor, Japanese telecom and tech giant SoftBank. Boston-based Cybereason has formed a partnership with Arm, the dominant developer of computer chip architecture, which was acquired by SoftBank in... Read more »
Origin Code Academy, one of San Diego’s few coding schools—for-profit companies that offer short-term vocational training in computer programming—said this month it will shutter on Nov. 16 after about three years in business.
The company opened in late 2015, offering a... Read more »
More days than not, Michael Colaneri’s home is a hotel room. So innovations like “geolocation” sensors that automatically unlock his room door and adjust the thermostat when he’s nearby make the constant change easier—sometimes.
“My experience has been exceptionally inconsistent,” he... Read more »
Venture Partner, OrbiMed Advisors
CEO, SNUPI Technologies
Partner, Emerging Companies and Life Sciences, Cooley LLP
Co-founder and CEO of ExtraHop Networks
Chairman of the Board, Oncothyreon
CEO, Accelerator Corporation; CEO and Director, Acylin Therapeutics
Chair, Computer Science and Engineering, University of Washington
President and Director, Fred Hutchinson Cancer Research Center
Prof. of Computer Science and Engineering, Univ. of Washington
Co-Founder and CEO, Modumetal
Prof. Dept. of Medicine/Hematology, Univ. of Washington